Bruce Turner, M.D., Ph.D.
Dr. Bruce Turner is a medically trained oncologist with deep experience spanning genetic research, drug development and healthcare portfolio management. Prior to founding Xanadu, Dr. Turner spent five years at Hoffman-La Roche in various position of increasing responsibility in R&D and was vice president at Ionis Pharmaceuticals, Inc. working in cardiovascular/ metabolic drug development. Dr. […]
Todd Wider, M.D.
Dr. Todd Wider is the Chairman of the Board of Directors and Chief Medical Officer at Emendo Bio and serves as a consultant to numerous entities in the biotechnology space. Todd graduated from Princeton University and received a M.D. from Columbia College of Physicians and Surgeons. He completed his surgery and plastic and reconstructive surgery […]
Taylor Feehley, Ph.D.
Dr. Taylor Feehley is a published immunology researcher with experience in life science corporate development and strategy. Most recently, she served in various senior corporate strategy and development roles at Omega Therapeutics and Vedanta Biosciences. Prior to joining Vedanta, she was a Senior Research Analyst at Chardan with a specialty in genetic medicines, infectious disease, […]